Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer

Gut

Volumn 63, Issue 5, 2014, Pages 761-770

  Prorok Hamon, Maelle ^a   Friswell, Melissa K ^a   Alswied, Abdullah ^a   Roberts, Carol L ^a   Song, Fei ^a   Flanagan, Paul K ^a   Knight, Paul ^a   Codling, Caroline ^b   Marchesi, Julian R ^b,c   Winstanley, Craig ^a   Hall, Neil ^a   Rhodes, Jonathan M ^a   Campbell, Barry J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; VASCULOTROPIN;

AFAC GENE; ARTICLE; BACTERIAL GENE; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; CELL INVASION; CELL TRANSFER; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DSBA GENE; EPITHELIUM CELL; ESCHERICHIA COLI; FIMH GENE; FOSMID; GENE EXPRESSION; HTRA GENE; HUMAN; HUMAN CELL; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; LPFA GENE; NONHUMAN; OPERON; PKS GENE; POLYMERASE CHAIN REACTION; POLYP; PRIORITY JOURNAL; PYROSEQUENCING; ULCERATIVE COLITIS; UPREGULATION;

BACTERIAL ADHERENCE; BACTERIAL INTERACTIONS; BACTERIAL PATHOGENESIS; E. COLI; GUT INFLAMMATION;

ADHESINS, ESCHERICHIA COLI; BASE SEQUENCE; BIOLOGICAL MARKERS; CACO-2 CELLS; CASE-CONTROL STUDIES; CELL LINE; COLON; COLONIC NEOPLASMS; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; HEMAGGLUTININS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MOLECULAR SEQUENCE DATA; POLYKETIDE SYNTHASES; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84897964236     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-304739     Document Type: Article

References (56)

1. Flanagan P, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Biochem Soc Trans 2011;39:1067-72.
2. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13. (Pubitemid 28545991)
3. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by PCR-denaturing gradient gel electrophoresis. Infl amm Bowel Dis 2006;12:1136-45. (Pubitemid 44847471)
4. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis 2009;15:872-82.
5. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93. (Pubitemid 38962277)
6. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-associated bacterial flora in infl ammatory bowel disease. Inflamm Bowel Dis 2005;11:481-7.
7. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009;15:653-60.
8. Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998;115:281-6. (Pubitemid 28363420)
9. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal fl ora in inflammatory bowel disease. Gastroenterology 2002;122:44-54. (Pubitemid 34049193)
10. Kotlowski R, Bernstein CN, Sepheri S, et al. High prevalence of Escherichia coli belonging to the B2 and D phylogenetic groups in infl ammatory bowel disease. Gut 2007;56:669-75. (Pubitemid 46662933)
11. Sepehri S, Kotlowski R, Bernstein CN, et al. Microbial diversity of inflamed and non-inflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:675-83. (Pubitemid 46909981)
12. Glasser AL, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001;69:5529-37. (Pubitemid 32786488)
13. Subramanian S, Roberts CL, Hart CA, et al. Replication of colonic Crohn's disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother 2008;52:427-34. (Pubitemid 351170809)
14. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn' s disease. Gastroenterology 2004;127:412-21. (Pubitemid 39091889)
15. Ryan P, Kelly RG, Lee G, et al. Bacterial DNA within granulomas of patients with Crohn's disease - detection by laser capture microdissection and PCR. Am J Gastroenterol 2004;99:1539-43. (Pubitemid 39180104)
16. Miquel S, Peyretaillade E, Claret L, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS ONE 2010;5:e12714.
17. Bringer MA, Barnich N, Glasser AL, et al. HtrA stress protein is involved in intramacrophagic replication of adherent, invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun 2005;73:712-21. (Pubitemid 40165726)
18. Bringer MA, Rolhion N, Glasser AL, et al. The oxidoreductase DsbA plays a key role in the ability of the Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 to resist macrophage killing. J Bacteriol 2007;189:4860-71. (Pubitemid 47025598)
19. Chassaing B, Rolhion N, Vallee A, et al. Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest 2011;121:966-75.
20. Servin AL. Pathogenesis of Afa/Dr diffusely-adhering Escherichia coli. Clin Microbiol Rev 2005;18:264-92. (Pubitemid 40548294)
21. Mulvey MA. Adhesion and entry of uropathogenic Escherichia coli. Cell Microbiol 2002;4:257-71. (Pubitemid 34567594)
22. Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
23. Buc E, Dubois D, Sauvanet P, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 2013;8:e56964.
24. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-7. (Pubitemid 33706348)
25. Bilge SS, Clausen CR, Lau W, et al. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol 1989;171:4281-9. (Pubitemid 19190321)
26. Le Bouguenec C, Lalioui L, du Merle L, et al. Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens. J Clin Microbiol 2001;39:1738-45. (Pubitemid 32417013)
27. Nataro JP, Kaper JB, Robins-Browne R, et al. Patterns of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J 1987;6:829-31. (Pubitemid 17151028)
28. Roberts CL, Keita AV, Duncan SH, et al. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 2010;59:1331-9.
29. Cane G, Ginouves A, Marchetti S, et al. HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell Microbiol 2010;12:640-53.
30. Waldner MJ, Wirtz S, Jefremow A, et al. VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. J Exp Med 2010;207:2855-68.
31. Labigne-Roussel A, Schmidt MA, Walz W, et al. Genetic organization of the afimbrial adhesin operon and nucleotide sequence from a uropathogenic Escherichia coli gene encoding an afimbrial adhesin. J Bacteriol 1985;162:1285-92. (Pubitemid 15012296)
32. Le Bouguenec C, Servin AL. Diffusely adherent Escherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol Letts 2006;256:185-94. (Pubitemid 43356788)
33. Sansonetti PJ, Phalipon A. M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol 1999;11:193-203. (Pubitemid 29358578)
34. Hase K, Kawano K, Nochi T, et al. Uptake through glycoprotein 2 of FimH(+) bacteria by M-cells initiates mucosal immune response. Nature 2009;462:226-30.
35. Fujimura Y, Kamoi R, Iida M. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut 1996;38:724-32. (Pubitemid 26167481)
36. Krauss A, Agaimy A, Neumann H, et al. Characterization of lymphoid follicles with red ring signs as first manifestation of early Crohn's disease by conventional histopathology and confocal laser endomicroscopy. Int J Clin Exp Pathol 2012;5:411-21.
37. Maunory V, Mordon S, Geboes K, et al. Early vascular changes in Crohn's disease: an endoscopic fluorescence study. Endoscopy 2000;32:700-5.
38. Barnich N, Darfeuille-Michaud A. Abnormal CEACAM6 expression in Crohn disease patients favors gut colonization and inflammation by adherent-invasive E. coli. Virulence 2010;1:281-2.
39. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn 's disease. J Clin Invest 2007;117:1566-74. (Pubitemid 46871341)
40. Bernet-Camard MF, Coconnier MH, Hudault S, et al. Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines. Gut 1996;38:248-53. (Pubitemid 26046822)
41. Korotkova N, Yarova-Yarovaya Y, Tchesnokova V, et al. Escherichia coli DraE adhesin-associated bacterial internalization by epithelial cells is promoted independently by decay-accelerating factor and carcinoembryonic antigen-related cell adhesion molecule binding and does not require the DraD invasin. Infect Immun 2008;76:3869-80.
42. Goluszko P, Popov V, Selvarangan R, et al. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell-line. J Infect Dis 1997;176:158-67. (Pubitemid 27272864)
43. Guignot J, Peiffer I, Bernet-Camard MF, et al. Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Escherichia coli that infect the human polarized intestinal Caco-2/TC7 cells. Infect Immun 2000;68:3554-63. (Pubitemid 30340457)
44. Berstad AE, Brandtzaeg P. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 1998;42:522-9. (Pubitemid 28186570)
45. Koretz K, Bruderlein S, Henne C, et al. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer 1992;66:810-14.
46. Betis F, Brest P, Hofman V, et al. Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins. Infect Immun 2003;71:1774-83. (Pubitemid 36368706)
47. Brest P, Betis F, Cuburu N, et al. Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains. Infect Immun 2004;72:5741-9. (Pubitemid 39303684)
48. Johnson JR, Skubitz KM, Nowicki BJ, et al. Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli. Infect Immun 1995;63:309-16.
49. Roggenbuck D, Hausdorf G, Martinez-Gamboa L, et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009;58:1620-28.
50. Sepehri S, Khafipour E, Bernstein CN, et al. Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1451-63.
51. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
52. Bataille F, Rohrmeier C, Bates R, et al. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis 2008;14:1514-27.
53. Flier SN, Tanjore H, Kokkotou EG, et al. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 2010;285:20202-12.
54. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002;8:10-16. (Pubitemid 34044673)
55. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-96. (Pubitemid 39061110)
56. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007;317:124-7. (Pubitemid 47056471)